Our founder/CEO/CSO, Sareina Wu, was invited to speak at the RASUS Global events: Next Generation Cell & Gene Therapy conference. (November 8-9, 2021)
GenomeFrontier’s founder and Chief Scientific Officer, Sareina Wu, was recently interviewed by BioSpace for an article regarding non-viral vectors’ impact on CAR-T cell therapy.
2021-04-26Our founder/CEO/CSO, Sareina Wu, was an invited speaker at the 7th Cell & Gene Therapy Summit (Live Online via Zoom). (July 19-21, 2022)
2022-07-11